Cutler Group’s Replimune Group REPL Stock Holding History

Cutler Group’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,000	Closed	-$1K	–	3343
2023 Q4	$1K	Buy	+1,000	New	+$11.6K	﹤0.01%	3416

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's REPL Position: Q1 2024 in Review

Cutler Group increased its Replimune Group (REPL) stake by 133% in Q1 2024, buying an estimated $3.28K and bringing the position to 700 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Cutler Group first reported a position in REPL in Q4 2023 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

Cutler Group held 700 shares of Replimune Group worth $5K as of Q1 2024.
Cutler Group bought 400 Replimune Group shares in Q1 2024, an estimated $3.28K.
Replimune Group made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1575 holding.
Cutler Group first reported a position in Replimune Group in Q4 2023 and has held it in 2 quarters since.
150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.